Skip to main content

Table 1 Baseline characteristics

From: Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children

PATIENT TRANSMISSION GENDER Age(years+months) CATEGORY(CDC) TANNER * LIPODYSTROPHY
1 UNKNOWN GIRL 13 Y 7 M A1 III to V no
2 VERTICAL BOY 9 Y 10 M A3 I-I no
3 VERTICAL BOY 8 Y 3 M A1 I-I no
4 VERTICAL GIRL 9 Y 2 M C3 I-I no
5 VERTICAL BOY 10 Y C3 I-I no
6 VERTICAL BOY 14 Y 7 M B2 II-III lipoatrohy
7 VERTICAL BOY 8 Y 2 M B2 II-III lipohypertrophy
MEDIAN    133(99,177)    
  1. * Puberty stage. Tanner JM. Grow and adolescence (2aedition) Oxford. Blackwell Scientific publication. 1962